-
Start Preamble
ACTION:
Notice of application.
DATES:
Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration in accordance with 21 CFR 1301.34(a) on or before December 28, 2015. Such persons may also file a written request for a hearing on the application pursuant to 21 CFR 1301.43 on or before December 28, 2015.
ADDRESSES:
Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/ODXL, 8701 Morrissette Drive, Springfield, Virginia 22152. Request for hearings should be sent to: Drug Enforcement Administration, Attention: Hearing Clerk/LJ, 8701 Morrissette Drive, Springfield, Virginia 22152.
End Preamble Start Supplemental InformationSUPPLEMENTARY INFORMATION:
The Attorney General has delegated her authority under the Controlled Substances Act to the Administrator of the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority to exercise all necessary functions with respect to the promulgation and implementation of 21 CFR part 1301, incident to the registration of manufacturers, distributors, dispensers, importers, and exporters of controlled substances (other than final orders in connection with suspension, denial, or revocation of registration) has been redelegated to the Deputy Assistant Administrator of the DEA Office of Diversion Control (“Deputy Assistant Administrator”) pursuant to section. 7 of 28 CFR part 0, appendix to subpart R.
In accordance with 21 CFR 1301.34(a), this is notice that on December 03, 2014, VHG Labs DBA LGC Standards Warehouse, 3 Perimeter Road, Manchester, New Hampshire 03103 applied to be registered as an importer of the following basic classes of controlled substances:
Controlled substance Schedule 3-Fluoro-N-methylcathinone (3-FMC) (1233) I Cathinone (1235) I Methcathinone (1237) I 4-Fluoro-N-methylcathinone (4-FMC) (1238) I Pentedrone (a-methylaminovalerophenone) (1246) I Mephedrone (4-Methyl-N-methylcathinone) (1248) I 4-Methyl-N-ethylcathinone (4-MEC) (1249) I Naphyrone (1258) I N-Ethylamphetamine (1475) I N,N-Dimethylamphetamine (1480) I Fenethylline (1503) I 4-Methylaminorex (cis isomer) (1590) I Gamma Hydroxybutyric Acid (2010) I Methaqualone (2565) I Mecloqualone (2572) I JWH-250 (1-Pentyl-3-(2-methoxyphenylacetyl) indole) (6250) I SR-18 (Also known as RCS-8) (1-Cyclohexylethyl-3-(2-methoxyphenylacetyl) Indole) (7008) I 5-Fluoro-UR-144 and XLR11 [1-(5-Flouro-pentyl)-1H-indol-3-yl] (2,2,3,3-tetramethylcyclopropyl) methanone (7011) I AB-FUBINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl) -1-(4-fluorobenzyl)-1H-indazole-3-carboxamide) (7012) I JWH-019 (1-Hexyl-3-(1-naphthoyl)indole) (7019) I ADB-PINACA (N-1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide) (7035) I APINACA and AKB48 N-(1-Adamantyl)-1-pentyl-1H-indazole-3-carboxamide (7048) I Start Printed Page 73831 JWH-081 (1-Pentyl-3-(1-(4-methoxynaphthoyl) Indole) (7081) I SR-19 (Also known as RCS-4) (1-Pentyl-3-[(4-methoxy)-benzoyl] indole (7104) I JWH-018 (also known as AM678) (1-Pentyl-3-(1-naphthoyl)indole) (7118) I JWH-122 (1-Pentyl-3-(4-methyl-1-naphthoyl)Indole) (7122) I UR-144 (1-Pentyl-1H-indol-3-yl) (2,2,3,3-tetramethylcyclopropyl) methanone (7144) I JWH-073 (1-Butyl-3-(1-naphthoyl)indole) (7173) I JWH-200 (1-[2-(4-Morpholinyl)ethyl]-3-(1-naphthoyl)indole) (7200) I AM-2201 (1-(5-Fluoropentyl)-3-(1-naphthoyl) Indole) (7201) I JWH-203 (1-Pentyl-3-(2-chlorophenylacetyl)Indole) (7203) I PB-22 (Quinolin-8-yl 1-pentyl-1H-indole-3-carboxylate) (7222) I 5F-PB-22 (Quinolin-8-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate) (7225) I Alpha-ethyltryptamine (7249) I Ibogaine (7260) I CP-47,497 (5-(1,1-Dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl-phenol) (7297) I CP-47497 C8 Homologue (5-(1,1-Dimethyloctyl)-2-[(1R,3S)3-hydroxycyclohexyl-phenol) (7298) I Lysergic acid diethylamide (7315) I 2,5-Dimethoxy-4-(n)-propylthiophenethylamine (2C-T-7) (7348) I Marihuana (7360) I Tetrahydrocannabinols (7370) I Parahexyl (7374) I Mescaline (7381) I 2-(4-Elthylthio-2,5-dimethoxyphenyl) ethanamine (2C-T-2) (7385) I 3,4,5-Trimethoxyamphetamine (7390) I 4-Bromo-2,5-dimethoxyamphetamine (7391) I 4-Bromo-2,5-dimethoxyphenethylamine (7392) I 4-Methyl-2,5-dimethoxyamphetamine (7395) I 2,5-Dimethoxyamphetamine (7396) I JWH-398 (1-Pentyl-3-(4-chloro-1-naphthoyl)Indole (7398) I 2,5-Dimethoxy-4-ethylamphetamine (7399) I 3,4-Methylenedioxyamphetamine (7400) I 5-Methoxy-3,4-methylenedioxyamphetamine (7401) I N-Hydroxy-3,4-methylenedioxyamphetaimine (7402) I 3,4-Methylenedioxy-N-ethylamphetamine (7404) I 3,4-Methylenedioxymethamphetamine (7405) I 4-Methoxyamphetamine (7411) I Peyote (7415) I 5-Methoxy-N-N-dimethyltryptamine (7431) I Alpha-methyltryptamine (7432) I Bufotenine (7433) I Diethyltryptamine (7434) I Dimethyltryptamine (7435) I Psilocybin (7437) I Psilocyn (7438) I 5-Methoxy-N,N-diisopropyltryptamine (7439) I N-Ethyl-1-phenylcyclohexylamine (7455) I 1-(1-Phenylcyclohexyl)pyrrolidine (7458) I 1-[1-(2-Thienyl)cyclohexyl]piperidine (7470) I 1-[1-(2-Thienyl)cyclohexyl]pyrrolidine (7473) I N-Ethyl-3-piperidyl benzilate (7482) I N-Methyl-3-piperidyl benzilate (7484) I N-Benzylpiperazine (7493) I 4-Methyl-alphapyrrolidinopropiophenone (4-MePPP) (7498) I 2-(2,5-Dimethoxy-4-methylphenyl) ethanamine (2C-D) (7508) I 2-(2,5-Dimethoxy-4-ethylphenyl) ethanamine (2C-E) (7509) I 2-(2,5-Dimethoxyphenyl) ethanamine (2C-H) (7517) I 2-(4-lodo-2,5-dimethoxyphenyl) ethanamine (2C-I) (7518) I 2-(4-Chloro-2,5-dimethoxyphenyl) ethanamine (2C-C) (7519) I 2-(2,5-Dimethoxy-4-nitro-phenyl) ethanamine (2C-N) (7521) I 2-(4-Isopropylthio)-2,5-dimethoxyphenyl) ethanamine (2C-T-4) (7532) I MDPV (3,4-Methylenedioxypyrovalerone) (7535) I 2-(4-bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine (25B-NBOMe) (7536) I 2-(4-chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine (25C-NBOMe) (7537) I Methylone (3,4-Methylenedioxy-N-methylcathinone) (7540) I Butylone (7541) I Pentylone (7542) I alpha-pyrrolidinopentiophenone (a-PVP) (7545) I alpha-pyrrolidinobutiophenone (a-PBP) (7546) I AM-694 (1-(5-Fluropentyl)-3-(2-iodobenzoyl)Indole) (7694) I Acetyldihydrocodeine (9051) I Benzylmorphine (9052) I Codeine-N-oxide (9053) I Cyprenorphine (9054) I Desomorphine (9055) I Etorphine (except HCI) (9056) I Start Printed Page 73832 Codeine methylbromide (9070) I Dihydromorphine (9145) I Difenoxin (9168) I Heroin (9200) I Hydromorphinol (9301) I Methyldesorphine (9302) I Methyldihydromorphine (9304) I Morphine methylbromide (9305) I Morphine methylsulfonate (9306) I Morphine-N-oxide (9307) I Myrophine (9308) I Nicocodeine (9309) I Nicomorphine (9312) I Normorphine (9313) I Pholcodine (9314) I Thebacon (9315) I Acetorphine (9319) I Drotebanol (9335) I Acetylmethadol (9601) I Allylprodine (9602) I Alphacetylmethadol except levo-alphacetyl-methadol (9603) I Alphameprodine (9604) I Alphamethadol (9605) I Benzethidine (9606) I Betacetylmethadol (9607) I Betameprodine (9608) I Betamethadol (9609) I Betaprodine (9611) I Clonitazene (9612) I Dextromoramide (9613) I Diampromide (9615) I Dimenoxadol (9617) I Dimepheptanol (9618) I Dimethylthiambutene (9619) I Dioxaphetyl butyrate (9621) I Dipipanone (9622) I Ethylmethylthiambutene (9623) I Etonitazene (9624) I Etoxeridine (9625) I Furethidine (9626) I Ketobemidone (9628) I Levomoramide (9629) I Levophenacylmorphan (9631) I Morpheridine (9632) I Noracymethadol (9633) I Normethadone (9635) I Norpipanone (9636) I Phenadoxone (9637) I Phenoperidine (9641) I Piritramide (9642) I Proheptazine (9643) I Properidine (9644) I Racemoramide (9645) I Trimeperidine (9646) I Phenomorphan (9647) I Propiram (9649) I 1-Methyl-4-phenyl-4-propionoxypiperdine (9661) I 1-(2-Phenylethyl)-4-phenyl-4-acetoxypiperdine (9663) I Tilidine (9750) I Para-Fluorofentanyl (9812) I 3-Methylfentanyl (9813) I Alpha-methylfentanyl (9814) I Acetyl-alpha-methylfentanyl (9815) I Beta-hydroxyfentanyl (9830) I Beta-hydroxy-3-methylfentanyl (9831) I Alpha-methylthiofentanyl (9832) I 3-Methylthiofentanyl (9833) I Thiofentanyl (9835) I Methamphetamine (1105) II Phenmetrazine (1631) II Amobarbital (2125) II Pentobarbital (2270) II Secobarbital (2315) II Glutethimide (2550) II Start Printed Page 73833 Nabilone (7379) II 1-Phenylcyclohexylamine (7460) II Phencyclidine (7471) II Phenylacetone (8501) II 1-Piperidinocyclohexanecarbonitrile (8603) II Alphaprodine (9010) II Anileridine (9020) II Etorphine HCI (9059) II Dihydrocodeine (9120) II Diphenoxylate (9170) II Ecgonine (9180) II Ethylmorphine (9190) II Levomethorphan (9210) II Levorphanol (9220) II Isomethadone (9226) II Meperidine (9230) II Meperidine intermediate-A (9232) II Meperidine intermediate-B (9233) II Meperidine intermediate-C (9234) II Metazocine (9240) II Metopon (9260) II Dextropropoxyphene, bulk (non-dosage forms) (9273) II Dihydroetorphine (9334) II Levo-alphacetylmethadol (9648) II Noroxymorphone (9668) II Phenazocine (9715) II Piminodine (9730) II Racemethorphan (9732) II Racemorphan (9733) II Alfentanil (9737) II Remifentanil (9739) II Sufentanil (9740) II Carfentanil (9743) II Tapentadol (9780) II Bezitramide (9800) II Moramide-intermediate (9802) II The company plans to import analytical reference standards for distribution to its customers for research and analytical purposes. Placement of these drug codes onto the company's registration does not translate into automatic approval of subsequent permit applications to import controlled substances.
Approval of permit applications will occur only when the registrant's business activity is consistent with what is authorized under 21 U.S.C. 952(a)(2). Authorization will not extend to the import of FDA approved or non-approved finished dosage forms for commercial sale.
Start SignatureDated: November 19, 2015.
Louis J. Milione,
Deputy Assistant Administrator.
[FR Doc. 2015-29934 Filed 11-24-15; 8:45 am]
BILLING CODE 4410-09-P
Document Information
- Published:
- 11/25/2015
- Department:
- Drug Enforcement Administration
- Entry Type:
- Notice
- Action:
- Notice of application.
- Document Number:
- 2015-29934
- Dates:
- Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration in accordance with 21 CFR 1301.34(a) on or before December 28, 2015. Such persons may also file a written request for a hearing on the application pursuant to 21 CFR 1301.43 on or before December 28, 2015.
- Pages:
- 73830-73833 (4 pages)
- Docket Numbers:
- Docket No. DEA-392
- PDF File:
- 2015-29934.pdf